Received: 29 December 2021
Accepted: 22 August 2022
First Online: 3 November 2022
: This study is conducted in accordance with the declaration of Helsinki and the Japanese Ethical Guidelines for Medical and Biological Research Involving Human Subjects [CitationRef removed]. The study protocol was approved with a waiver of consent by the ethics committee of Kyoto University Graduate School and Faculty of Medicine (no. R2710-2) and the ethics committees of CPMC and IH. The ethics committee of Kyoto University Graduate School and Faculty of Medicine also approved the protocol on behalf of UPSH as UPSH did not hold such a committee.
: Not applicable.
: AS has no competing interests. TAF reports grants and personal fees from Mitsubishi-Tanabe, personal fees from MSD, and personal fees from Shionogi outside the submitted work. NW has received research funds from the Japanese Ministry of Health Labor and Welfare and the Japanese Ministry of Education, Science, and Technology, and royalties from Sogensha, Paquet, and Akatsuki, independently of this study protocol. KM and TM have no competing interests.